For All The Latest Medical News, Health News, Research News, COVID-19 News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Cardiology News, Epigenetic News, Cancer News, Doctor News, Hospital News

BREAKING NEWS
Nikhil Prasad  Fact checked by:Thailand Medical News Team Jul 23, 2024  4 months, 2 weeks, 6 days, 13 minutes ago

The role of Phenylalanine in heart failure

1914 Shares
facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
The role of Phenylalanine in heart failure
Nikhil Prasad  Fact checked by:Thailand Medical News Team Jul 23, 2024  4 months, 2 weeks, 6 days, 13 minutes ago
Cardiology Updates: Heart failure (HF) remains a leading cause of illness and death worldwide, affecting millions of people. Despite advances in medical treatments, the need for better tools to predict outcomes in HF patients is crucial. A recent study sheds light on phenylalanine (PHE), an amino acid, as a significant marker in understanding and predicting heart failure outcomes.


The role of Phenylalanine in heart failure

The Research Team and Institutions
This insightful study was conducted by a team of researchers from several institutions in Taiwan. The authors include Dr Jih-Kai Yeh, Dr Yi-Liang Tsou, Dr Min-Hui Liu, Dr Wei-Siang Chen, Dr Cheng-I Cheng, Dr Kuo-Li Pan, Dr Chao-Hung Wang, and Dr I-Chang Hsieh. They are affiliated with the Chang Gung Memorial Hospital in Taoyuan, Keelung, and Kaohsiung, the Heart Failure Research Center, and the School of Medicine at Chang Gung University.
 
Understanding the Study
Heart failure is a condition where the heart struggles to pump blood efficiently, leading to a cascade of health issues. Traditionally, biomarkers like B-type natriuretic peptide (BNP) have been used to assess the severity and prognosis of HF. However, the exploration of PHE offers a new dimension in understanding HF.
 
This Cardiology Updates news report delves into a study that retrospectively analyzed 550 HF patients to assess the prognostic value of PHE levels before hospital discharge. Furthermore, the study explored how phenylalanine (PHE) is metabolized in the body, involving 24 patients in a detailed examination of PHE handling across various organs, including the heart, liver, kidneys, muscles, and lungs.
 
Key Findings of the Study
The study found that elevated levels of PHE (≥65.6 µM) before discharge were significantly associated with higher mortality rates over a median follow-up period of 4.5 years. This underscores the potential of PHE as a critical prognostic marker in HF.
 
Inter-Organ Crosstalk
The research also provided insights into how different organs manage PHE. In patients with HF, the skeletal muscle releases more PHE, while the liver and heart exhibit reduced uptake. This imbalance in PHE metabolism correlates with HF severity, including worse functional class, higher BNP levels, and increased systemic inflammation.
 
Clinical Implications
The findings highlight the importance of monitoring metabolic changes in HF patients. PHE levels could serve as an additional tool to guide treatment strategies, complementing existing markers like BNP.
 
Why Phenylalanine Matters
PHE is an essential amino acid obtained from food and necessary for producing vital compounds like dopamine and adrenaline. In HF, the body's stress response leads to increased PHE release from muscles to support these metabolic needs. However, when the liver and heart fail to effectively manage this inf lux, PHE levels rise in the blood, indicating a state of metabolic distress.
 
The study demonstrated that higher PHE levels were linked to worse outcomes, including higher mortality. This was particularly evident in patients with acute HF, where the body struggles to maintain metabolic balance.
 
Implications for Future Research
The findings pave the way for more comprehensive research on metabolic biomarkers in HF. Future studies could explore the role of amino acids in early detection and personalized treatment approaches. Understanding the intricate balance of amino acid metabolism could offer new therapeutic targets and improve patient outcomes.
 
The study also suggests that diets low in PHE might benefit HF patients, potentially reducing the metabolic burden on the body and improving overall health.
 
Conclusion
This research underscores the significance of phenylalanine in understanding and managing heart failure. Elevated PHE levels serve as a robust marker for predicting patient outcomes, offering a new avenue for clinical assessment and intervention.
 
The study findings were published in the peer-reviewed Journal of Clinical Medicine.
https://www.mdpi.com/2077-0383/13/14/4251
 
For the latest Cardiology Updates, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/valosin-containing-protein-deficiency-the-hidden-culprit-behind-heart-failure
 
https://www.thailandmedical.news/news/gut-health-and-immune-inflammation-new-insights-into-heart-failure

MOST READ

Nov 19, 2024  23 days ago
Nikhil Prasad
Nov 05, 2024  1 month ago
Nikhil Prasad
Nov 05, 2024  1 month ago
Nikhil Prasad
Jul 25, 2024  5 months ago
Nikhil Prasad
Jul 24, 2024  5 months ago
Nikhil Prasad
Jun 10, 2023  2 years ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer